← Open Payments lookup

BRANDON PANKIEWICZ: Open Payments

NPI 1255980058 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,918 in 130 payments from 14 companies in 2025. Trend: 2023 $1,916 · 2024 $2,284 · 2025 $1,918

Food & beverage: $1,816Education: $101
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.64$647
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)23$451
Otsuka America Pharmaceutical, Inc.19$315
Alkermes, Inc.4$96
Janssen Pharmaceuticals, Inc3$69
Neurocrine BioSciences, Inc.3$64
Axsome Therapeutics, Inc.3$63
Takeda Pharmaceuticals U.S.A., Inc.2$49
Vanda Pharmaceuticals Inc.2$47
E.R. Squibb & Sons, L.L.C.2$32

Products named: CAPLYTA, UZEDY, ABILIFY ASIMTUFII, AUSTEDO XR, REXULTI, LYBALVI, INGREZZA, Auvelity.

Industry payments across PA — which companies pay providers there.